Metabolic-epigenetic reprogramming of airway fibroblasts by K + N therapy suppresses IL-33 and ameliorates allergic asthma.
- DOI
- 10.1016/j.intimp.2026.117386
- Published
- 2026 Sep 9
- Container
- International immunopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117386,
title = {Metabolic-epigenetic reprogramming of airway fibroblasts by K + N therapy suppresses IL-33 and ameliorates allergic asthma.},
author = {Sun X and Zhang Y and Zheng Y and Mi Y and Huang H and Yu Y and Li L and Yang P and Zheng P},
year = {2026},
journal = {International immunopharmacology},
doi = {10.1016/j.intimp.2026.117386},
url = {https://doi.org/10.1016/j.intimp.2026.117386}
}RIS
TY - JOUR TI - Metabolic-epigenetic reprogramming of airway fibroblasts by K + N therapy suppresses IL-33 and ameliorates allergic asthma. AU - Sun X AU - Zhang Y AU - Zheng Y AU - Mi Y AU - Huang H AU - Yu Y AU - Li L AU - Yang P AU - Zheng P PY - 2026 JO - International immunopharmacology DO - 10.1016/j.intimp.2026.117386 UR - https://doi.org/10.1016/j.intimp.2026.117386 ER -
APA
X, S., Y, Z., Y, Z., Y, M., H, H., Y, Y., L, L., P, Y., & P, Z. (2026). Metabolic-epigenetic reprogramming of airway fibroblasts by K + N therapy suppresses IL-33 and ameliorates allergic asthma.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117386
Source records
- pubmed · retrieved 2026-09-25T05:50:51.035Z